Po-Yu Tseng

Pentraxin 3 Predicts Arteriovenous Fistula Functional Patency Loss and Mortality in Chronic Hemodialysis Patients

D. Tarng, Shuo-Ming Ou, Chih-Yu Yang, 2022, American Journal of Nephrology.

Long-term Outcomes of Parathyroidectomy in Kidney Transplant Recipients with Persistent Hyperparathyroidism

D. Tarng, Wu-chang Yang, Chih-Yu Yang, 2015, Kidney and Blood Pressure Research.

Prediction of the development of acute kidney injury following cardiac surgery by machine learning

Chih-Yu Yang, Kuan-Ming Chiu, Shih-Ping Hsu, 2020, Critical Care.

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Eddie B. S. Tan, Nishit P. Parikh, Rajan K. Patel, 2023, The Lancet.

Key pathological features characterize minimal change disease-like IgA nephropathy

D. Tarng, Chih-Ching Lin, Ming-Tsun Tsai, 2023, PloS one.

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

N. Perico, M. Jardine, V. Perkovic, 2023, The Lancet.